JO
SIOX

John Overdeck’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

John Overdeck’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-70,925
Closed -$30.9K – 3319
2022
Q4 		$30.9K Hold
70,925
– – ﹤0.01% 2645
2022
Q3 		$20K Sell
70,925
-100
-0.1% -$34 ﹤0.01% 2383
2022
Q2 		$26K Sell
71,025
-24,421
-26% -$10.1K ﹤0.01% 2388
2022
Q1 		$64K Buy
95,446
+64,839
+212% +$55.1K ﹤0.01% 2475
2021
Q4 		$39K Sell
30,607
-142,530
-82% -$253K ﹤0.01% 4154
2021
Q3 		$376K Sell
173,137
-192,255
-53% -$418K ﹤0.01% 3487
2021
Q2 		$998K Sell
365,392
-182,761
-33% -$454K ﹤0.01% 2479
2021
Q1 		$1.43M Buy
+548,153
New +$1.55M ﹤0.01% 1990
2020
Q4 		– Sell
-308,318
Closed -$1.42M – 3888
2020
Q3 		$1.42M Buy
308,318
+256,498
+495% +$847K 0.01% 1526
2020
Q2 		$146K Buy
51,820
+41,307
+393% +$132K ﹤0.01% 2722
2020
Q1 		$26K Buy
+10,513
New +$38K ﹤0.01% 2965
2019
Q1 		– Sell
-8,424
Closed -$67K – 3575
2018
Q4 		$67K Sell
8,424
-4,714
-36% -$68K ﹤0.01% 2848
2018
Q3 		$254K Sell
13,138
-31,676
-71% -$576K ﹤0.01% 2872
2018
Q2 		$810K Sell
44,814
-26,393
-37% -$389K ﹤0.01% 2310
2018
Q1 		$758K Buy
71,207
+51,582
+263% +$829K ﹤0.01% 2205
2017
Q4 		$827K Buy
+19,625
New +$881K ﹤0.01% 2090

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

John Overdeck's SIOX Position: Q1 2023 in Review

John Overdeck sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 70,925 shares — an estimated $30.9K sold.

John Overdeck first reported a position in SIOX in Q4 2017 and held it in 16 quarters. The position peaked at $1.43M in Q1 2021. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • John Overdeck reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • John Overdeck sold 70,925 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $30.9K.
  • John Overdeck first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2017 and held it in 16 quarters.
  • John Overdeck's Sio Gene Therapies Inc. Common Stock position peaked at $1.43M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.